Drugs Made In America Acquisition II Corp. Ordinary Shares

Drugs Made In America Acquisition II Corp. Ordinary Shares

DMII - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$511.5M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Drugs Made In America Acquisition II Corp. Ordinary SharesDrugs Made In America Acquisition II Corp. Ordinary Shares33.8-3%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$511.50 Million
Enterprise Value$511.78 Million
Earnings per Share$0.16
Beta0.04
Outstanding Shares50,000,000

Return

Return on Equity2.62%ROE
Return on Assets2.53%
Return on Invested Capital-0.28%

Valuation & Multiples

P/E Ratio33.8P/E Ratio
PEG-0.29PEG
Price to Sales-Price to Sales
Price to Book Ratio1.14Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-353.59
Enterprise Value to Net Income39
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %31.49%▼ 59.47%
Total Invested$160.33M▼ 64.96%
Investors Holding27▼ 43.00%

About Drugs Made In America Acquisition II Corp. Ordinary Shares

2 employees
CEO: Roger Bendelac

Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a rec...